Literature DB >> 8401362

Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation.

G W Dewald1, C R Schad, E R Christensen, M E Law, A R Zinsmeister, P G Stalboerger, S M Jalal, R C Ash, R B Jenkins.   

Abstract

We investigated the efficacy of fluorescence-labelled chromosome probes (CEP-X/Y) for the X and Y chromosomes to study patients who have had opposite sex BMT. These probes hybridize to the centromere region of the X chromosome and nearly the entire long arm of the Y chromosome. These probes are direct-labelled and produce X and Y signals that can be simultaneously viewed and readily distinguished from each other by color and size after only five brief washes. We investigated BM specimens from 20 normal donors and 16 patients who had undergone an opposite sex BMT. We found no significant interinvestigator differences with respect to scoring XX or XY interphase cells. The 'normal range' for XX cells in males was up to 0.628% and for XY cells in females it was up to 0.299%. Each of the specimens from the patients who underwent BMT had a significant number of donor cells compared with normal range. We suggest that an economical, rapid and accurate cytogenetic test can be achieved by using these probes as an adjunct to conventional cytogenetics.

Entities:  

Mesh:

Year:  1993        PMID: 8401362

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  12 in total

Review 1.  Demystified ... FISH.

Authors:  J J Waters; A L Barlow; C P Gould
Journal:  Mol Pathol       Date:  1998-04

2.  Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research.

Authors:  A Rhoton-Vlasak; P Y Lu; K M Barud; G W Dewald; D G Hammitt
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

3.  Pilot studies for proficiency testing using fluorescence in situ hybridization with chromosome-specific DNA probes: a College of American Pathologists/American College of Medical Genetics Program.

Authors:  G W Dewald; A R Brothman; M G Butler; L D Cooley; S R Patil; I A Saikevych; N R Schneider
Journal:  Arch Pathol Lab Med       Date:  1997-04       Impact factor: 5.534

4.  Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens.

Authors:  A J Dawson; J McGowan-Jordan; J Chernos; J Xu; J Lavoie; J C Wang; M Steinraths; S Shetty
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

Review 5.  Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines.

Authors:  Joaquim Vives; Aina Casademont-Roca; Lluís Martorell; Núria Nogués
Journal:  Bone Marrow Transplant       Date:  2020-02-05       Impact factor: 5.483

Review 6.  Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.

Authors:  Gordon W Dewald
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  Interphase fluorescence in situ hybridisation of the X and Y chromosomes in the human eye.

Authors:  G Wollensak; E J Perlman; W R Green
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

8.  Long-term follow-up of allogeneic bone marrow transplantation after reduced-intensity conditioning in patients with chronic myelogenous leukemia in the chronic phase.

Authors:  Shinichiro Okamoto; Reiko Watanabe; Satoshi Takahashi; Takehiko Mori; Tohru Izeki; Hitomi Nagayama; Akaru Ishida; Nobuyuki Takayama; Kenji Yokoyama; Arinobu Tojo; Shigetaka Asano; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

9.  Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation.

Authors:  Ghada I Mossallam; Azza M Kamel; Barry Storer; Paul J Martin
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

10.  Automated detection of residual cells after sex-mismatched stem-cell transplantation - evidence for presence of disease-marker negative residual cells.

Authors:  Jörn Erlecke; Isabell Hartmann; Martin Hoffmann; Torsten Kroll; Heike Starke; Anita Heller; Alexander Gloria; Herbert G Sayer; Tilman Johannes; Uwe Claussen; Thomas Liehr; Ivan F Loncarevic
Journal:  Mol Cytogenet       Date:  2009-05-29       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.